SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 (SPMA) Fundamental Analysis & Valuation

NYSE:SPMA

Current stock price

24.97 USD
-0.04 (-0.16%)
Last:

This SPMA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SPMA Profitability Analysis

1.1 Basic Checks

  • In the past year SPMA was profitable.
  • In the past year SPMA has reported a negative cash flow from operations.
SPMA Yearly Net Income VS EBIT VS OCF VS FCFSPMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2025 0 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.25%, SPMA is in line with its industry, outperforming 54.96% of the companies in the same industry.
  • SPMA has a Return On Equity (5.08%) which is in line with its industry peers.
  • With a decent Return On Invested Capital value of 6.80%, SPMA is doing good in the industry, outperforming 76.86% of the companies in the same industry.
Industry RankSector Rank
ROA 3.25%
ROE 5.08%
ROIC 6.8%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPMA Yearly ROA, ROE, ROICSPMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2025 2 4 6

1.3 Margins

  • SPMA's Profit Margin of 25.05% is fine compared to the rest of the industry. SPMA outperforms 64.46% of its industry peers.
  • SPMA's Operating Margin of 64.29% is amongst the best of the industry. SPMA outperforms 97.52% of its industry peers.
  • SPMA's Gross Margin of 67.35% is fine compared to the rest of the industry. SPMA outperforms 76.03% of its industry peers.
Industry RankSector Rank
OM 64.29%
PM (TTM) 25.05%
GM 67.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPMA Yearly Profit, Operating, Gross MarginsSPMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SPMA Health Analysis

2.1 Basic Checks

SPMA Yearly Shares OutstandingSPMA Yearly Shares OutstandingYearly Shares Outstanding 2025 5M 10M 15M 20M
SPMA Yearly Total Debt VS Total AssetsSPMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • SPMA has a Debt/Equity ratio of 0.52. This is a neutral value indicating SPMA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.52, SPMA is in the better half of the industry, outperforming 64.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
SPMA Yearly LT Debt VS Equity VS FCFSPMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.38 indicates that SPMA may have some problems paying its short term obligations.
  • SPMA has a Current ratio of 0.38. This is amonst the worse of the industry: SPMA underperforms 80.58% of its industry peers.
  • A Quick Ratio of 0.38 indicates that SPMA may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.38, SPMA is doing worse than 80.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
SPMA Yearly Current Assets VS Current LiabilitesSPMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SPMA Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-221.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.02%

3.2 Future

  • Based on estimates for the next years, SPMA will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.98% on average per year.
  • The Revenue is expected to grow by 11.54% on average over the next years. This is quite good.
EPS Next Y-24.53%
EPS Next 2Y-14.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.14%
Revenue Next 2Y11.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SPMA Yearly Revenue VS EstimatesSPMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 20M 40M 60M 80M
SPMA Yearly EPS VS EstimatesSPMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. SPMA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.70, SPMA can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of SPMA indicates a slightly more expensive valuation: SPMA is more expensive than 73.97% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.96, SPMA is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 13.13, the valuation of SPMA can be described as correct.
  • The rest of the industry has a similar Price/Forward Earnings ratio as SPMA.
  • SPMA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.04.
Industry RankSector Rank
PE 28.7
Fwd PE 13.13
SPMA Price Earnings VS Forward Price EarningsSPMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPMA Per share dataSPMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as SPMA's earnings are expected to decrease with -14.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.98%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. SPMA Dividend Analysis

5.1 Amount

  • SPMA has a Yearly Dividend Yield of 13.62%, which is a nice return.
  • Compared to an average industry Dividend Yield of 6.96, SPMA pays a better dividend. On top of this SPMA pays more dividend than 82.23% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, SPMA pays a better dividend.
Industry RankSector Rank
Dividend Yield 13.62%

5.2 History

  • SPMA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
SPMA Yearly Dividends per shareSPMA Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 313.46% of the earnings are spent on dividend by SPMA. This is not a sustainable payout ratio.
DP313.46%
EPS Next 2Y-14.98%
EPS Next 3YN/A
SPMA Yearly Income VS Free CF VS DividendSPMA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2025 0 -50M -100M -150M
SPMA Dividend Payout.SPMA Dividend Payout, showing the Payout Ratio.SPMA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SPMA Fundamentals: All Metrics, Ratios and Statistics

SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29

NYSE:SPMA (3/17/2026, 4:10:03 PM)

24.97

-0.04 (-0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-11
Earnings (Next)05-27
Inst Owners6.3%
Inst Owner ChangeN/A
Ins Owners0.92%
Ins Owner ChangeN/A
Market Cap512.88M
Revenue(TTM)70.27M
Net Income(TTM)17.60M
Analysts78.18
Price Target42.99 (72.17%)
Short Float %N/A
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield 13.62%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP313.46%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date06-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.22%
Min EPS beat(2)-8.84%
Max EPS beat(2)-5.6%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)33.09%
Min Revenue beat(2)-13.21%
Max Revenue beat(2)79.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)26.77%
PT rev (3m)28.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.97%
EPS NY rev (1m)5.02%
EPS NY rev (3m)1.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.61%
Revenue NY rev (1m)-1.79%
Revenue NY rev (3m)-15.81%
Valuation
Industry RankSector Rank
PE 28.7
Fwd PE 13.13
P/S 7.3
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)0.87
EY3.48%
EPS(NY)1.9
Fwd EY7.62%
FCF(TTM)-4.39
FCFYN/A
OCF(TTM)-4.39
OCFYN/A
SpS3.42
BVpS16.86
TBVpS16.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.16
Profitability
Industry RankSector Rank
ROA 3.25%
ROE 5.08%
ROCE 8.6%
ROIC 6.8%
ROICexc 6.84%
ROICexgc 6.84%
OM 64.29%
PM (TTM) 25.05%
GM 67.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-221.79%
EPS Next Y-24.53%
EPS Next 2Y-14.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.02%
Revenue Next Year11.14%
Revenue Next 2Y11.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-187.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 / SPMA Fundamental Analysis FAQ

What is the fundamental rating for SPMA stock?

ChartMill assigns a fundamental rating of 2 / 10 to SPMA.


What is the valuation status for SPMA stock?

ChartMill assigns a valuation rating of 1 / 10 to SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 (SPMA). This can be considered as Overvalued.


Can you provide the profitability details for SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29?

SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 (SPMA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for SPMA stock?

The Price/Earnings (PE) ratio for SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 (SPMA) is 28.7 and the Price/Book (PB) ratio is 1.48.


What is the expected EPS growth for SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 (SPMA) stock?

The Earnings per Share (EPS) of SOUND POINT MERIDIAN CAP - SPMC 8 11/30/29 (SPMA) is expected to decline by -24.53% in the next year.